Station X

About Station X

Station X Inc. operated as a specialized bioinformatics company focused on solving big data challenges within the genomics sector. Founded in 2010 by Tod M. Klingler, Ph.D., Andrew R. MacBride, and Richard D. Goold, Ph.D., the San Francisco-based firm developed a cloud-based enterprise software platform to simplify the complex analysis of genome-scale data for clinical and research applications.

The company's core offering was GenePool™, a Software-as-a-Service (SaaS) platform built on Amazon Web Services (AWS). This system was engineered to manage, analyze, and visualize massive genomic and clinical data sets from large patient populations, enabling scientists and clinicians to identify biomarkers and accelerate diagnostic development. The platform's architecture was designed to securely handle petabytes of information, helping researchers shave months off their discovery and development timelines for genetic diseases and cancer.

Station X's business model was centered on providing subscription-based access to its GenePool platform. The primary clientele included pharmaceutical companies, biotechnology firms, and clinical researchers who required robust tools to translate raw DNA sequence data into verified biomarkers. The company secured multiple funding rounds, including a Series A round in 2010 and a significant $5 million Series B round in 2012 led by Runa Capital and including participation from Genomic Health. After its operational period, Station X was acquired by Roche and is no longer a standalone entity.